FDA Finds Flaws In Theranos' Zika Tests (techcrunch.com)
An anonymous reader quotes a report from TechCrunch: This past week, the U.S. Food and Drug Administration mandated testing for the Zika virus at all U.S. blood centers. That juices demand for Zika-testing technology, but one company that isn't welcome to provide it yet is Theranos. The beleaguered blood analysis startup has run afoul of the FDA, yet again, The Wall Street Journal reports (Warning: may be paywalled). Specifically, regulators found that in developing and testing a new Zika-diagnostic technology, Theranos failed to use proper patient safety protocols, the type approved by an institutional review board. Such protocols are critical in ensuring the ethical treatment of patients involved in studies, and their safety. Theranos had sought the same FDA authorization, but voluntarily withdrew its request once regulators called the startup out, this time, on the safety protocols issue.
She's like an 8 year old playing doctor at the playground. She has unbridled enthusiasm, uses lots of big words that she overheard adults using, and pushes all the other kids who make fun of her for pretending to be something she's not.
They really should get back in their lane and stick to selling bottles that keep hot things hot and cold things cold, imo
So you pre-emptively void a counter-example to establish an ad hoc save of your grouping statement?
There's a phrase for that.